KLK3 and prostate cancer: Furthermore, our findings when stratifying patients according to PSA nadir and initial D’Amico classification stress the importance of patient selection for upfront therapy and highlight the predictive value of PSA nadir levels in determining long-term outcomes for prostate cancer patients.